Condition

Recurrent Ovary Cancer clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• DT2216 with weekly paclitaxel for platinum-resistant ovarian cancer

  We are testing whether adding DT2216 to weekly paclitaxel is safe and tolerable for people with recurrent platinum‑resistant ovarian cancer.

  Recruiting at 2 sites Phase 1 Dana-Farber Cancer Institute · Boston, Massachusetts and 2 other locations · NCT06964009

• CIML NK cell therapy for recurrent ovarian cancer

  This study is testing a new treatment using special immune cells to see if it can help people with recurrent high-grade ovarian cancer feel better and improve their health.

  Recruiting Phase 1 Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT06321484

Related topics

Quick answers

How many Recurrent Ovary Cancer clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →